Wash‐in rate on the basis of dynamic contrast‐enhanced MRI: Usefulness for prostate cancer detection and localization
暂无分享,去创建一个
Seong Ho Park | Kyoung-Sik Cho | Choung-Soo Kim | S. Park | Y. Choi | Jeong Kon Kim | Kyoung-Sik Cho | Choung-Soo Kim | H. Ahn | Young Jun Choi | Seong Sook Hong | Hanjong Ahn | K. Cho | Seong Sook Hong | Young Jun Choi | Seong-Ho Park
[1] D. Johnston,et al. Detailed mapping of prostate carcinoma foci , 2000, Cancer.
[2] H. Thaler,et al. Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate? , 1996, The Journal of urology.
[3] G Brix,et al. Intra- and extracellular fluorouracil uptake: assessment with contrast-enhanced metabolic F-19 MR imaging. , 1998, Radiology.
[4] M. Rifkin,et al. MR imaging characteristics of noncancerous lesions of the prostate , 1992, Journal of magnetic resonance imaging : JMRI.
[5] S. Nishizawa,et al. A simplified double-injection method to quantify corebral blood flow and vascular reserve using iodine-123 IMP-SPECT , 2002, Annals of nuclear medicine.
[6] T. Stamey,et al. Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread , 1988, The American journal of surgical pathology.
[7] P. Scardino,et al. A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. , 1991, The Journal of urology.
[8] C W Piccoli,et al. Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. , 1994, Radiology.
[9] P. Carroll,et al. Focal therapy for prostate cancer 1996: maximizing outcome. , 1997, Urology.
[10] P. Marano,et al. Magnetic Resonance Imaging in Breast Cancer Recurrence , 2002, Breast Cancer Research and Treatment.
[11] J Kurhanewicz,et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. , 1999, Radiology.
[12] J R Thornbury,et al. Prostate cancer staging: should MR imaging be used?--A decision analytic approach. , 2000, Radiology.
[13] G Brix,et al. Multicompartment analysis of gadolinium chelate kinetics: Blood‐tissue exchange in mammary tumors as monitored by dynamic MR imaging , 1999, Journal of magnetic resonance imaging : JMRI.
[14] R. Troiano,et al. Fast spin-echo MR images of the pelvis obtained with a phased-array coil: value in localizing and staging prostatic carcinoma. , 1993, AJR. American journal of roentgenology.
[15] J Kurhanewicz,et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. , 2000, The Journal of urology.
[16] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[17] A. Scott,et al. A simple method for the analysis of clustered binary data. , 1992, Biometrics.
[18] P. Carroll,et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.
[19] C. Kuhl,et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? , 1999, Radiology.
[20] G Brix,et al. Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: Initial results , 1998, Journal of magnetic resonance imaging : JMRI.
[21] M. Kattan,et al. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results. , 2003, Radiology.
[22] P H Bland,et al. Prostate cancer: correlation of MR images with tissue optical density at pathologic examination. , 1991, Radiology.
[23] L J van Erning,et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. , 1994, Radiology.
[24] L R Schad,et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. , 1991, Journal of computer assisted tomography.
[25] Olivier Rouvière,et al. Characterization of time-enhancement curves of benign and malignant prostate tissue at dynamic MR imaging , 2003, European Radiology.
[26] T. Stamey,et al. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. , 2000, The Journal of urology.
[27] R. Oyen. Dynamic contrast-enhanced MRI of the prostate: Is this the way to proceed for characterization of prostatic carcinoma? , 2003, European Radiology.
[28] Xiao-Hua Zhou,et al. Statistical Methods in Diagnostic Medicine , 2002 .
[29] P. Wingo,et al. Cancer statistics, 1996 , 1996, CA: a cancer journal for clinicians.
[30] T. Stamey,et al. Large, organ confined, impalpable transition zone prostate cancer: association with metastatic levels of prostate specific antigen. , 1993, The Journal of urology.
[31] G P Liney,et al. Differentiation of prostatic carcinoma and benign prostatic hyperplasia: Correlation between dynamic Gd‐DTPA‐enhanced MR imaging and histopathology , 1999, Journal of magnetic resonance imaging : JMRI.
[32] H A Vrooman,et al. Detection of areas with viable remnant tumor in postchemotherapy patients with Ewing's sarcoma by dynamic contrast-enhanced MRI using pharmacokinetic modeling. , 2000, Magnetic resonance imaging.
[33] G P Liney,et al. In vivo magnetic resonance spectroscopy and dynamic contrast enhanced imaging of the prostate gland , 1999, NMR in biomedicine.
[34] S. F. Quinn,et al. MR imaging of prostate cancer with an endorectal surface coil technique: correlation with whole-mount specimens. , 1994, Radiology.
[35] C. Langlotz,et al. Staging of prostatic cancer: accuracy of MR imaging. , 1995, Radiology.
[36] W. J. Lorenz,et al. Pharmacokinetic Mapping of the Breast: A New Method for Dynamic MR Mammography , 1995, Magnetic resonance in medicine.